Skip to main content
SpringerLink
Log in

Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: A review

  • Reviews
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

This article reviews recent advances in understanding the role of myelin proteolipid protein (PLP) in autoimmune demyelination. It is drawn largely from work published within the last years and discusses the immunology of PLP in the historical context of what has been learned from extensive studies on the immune response to myelin basic protein (MBP). Despite the, fact that PLP is the major protein constituent of mammalian myelin, its role in autoimmune demyelination has not been widely recognized. The lack of understanding about the immunology of PLP is a direct result of the biochemical characteristics of the protein. PLP is a highly hydrophobic membrane protein with limited aqueous solubility. The hydrophobicity of PLP has thwarted, immunologic studies of the intact protein. Recent work has circumvented the technical obstacles of studying the intact protein by using soluble synthetic PLP peptides. This approach has rapidly resulted in a more definitive understanding of the immune response to PLP. Presently, the data indicate that:i) PLP is a major central nervous system (CNS) specific encephalitogen;ii) CD4+T cell reactivity to discrete PLP peptide determinants can mediate the development of acute chronic relapsing, and chronic progressive experimental autoimmune encephalomyelitis (EAE); andiii) T cell reactivity to multiple PLP determinants occurs in patients with multiple sclerosis (MS), the major human CNS demyleinating disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rivers, T. M., Sprunt, D. H., and Berry, G. P. 1933. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J. Exp. Med. 58:39–53.

    Google Scholar 

  2. Rivers, T. M., and Schwentker, F. F. 1935. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J. Exp. Med. 61:689–702.

    Google Scholar 

  3. Folch, J., and Lees, M. 1951. Proteolipides a new type of tissue lipoproteins, their isolation from brain. J. Biol. Chem. 191:807–817.

    Google Scholar 

  4. Olitsky, P. K., and Tal, C. 1952. Acute disseminated encephalomyelitis produced in mice by brain proteolipide (Folch-Lees). Proc. Soc. Exp. Biol. Med. 79:50–53.

    Google Scholar 

  5. Goldstein, N. P., Kolb, L. C., Mason, H. L., Sayre, G. P., and Karlson, A. G. 1953. Relationship of homologous brain proteolipid to allergic encephalomyelitis in guinea pigs. Neurology 3:609–614.

    Google Scholar 

  6. Waksman, B. H., Porter, H., Lees, M. B., Adams, R. D., and Folch, J. 1954. A study of the chemical nature of components of bovine white matter effective in producing allergic encephalomyelitis in the rabbit. J. Exp. Med. 100:451–471.

    Google Scholar 

  7. Waksman, B. H. 1959. Activity of proteolipid-containing fractions of nervous tissue in producing experimental “allergic” encephalomyelitis. Pages, 263–272,in Kies, M. W. and Alvord E. C., Jr., (eds.), “Allergic” Encephalomyelitis, Charles C. Thomas, Springfield, Illinois.

    Google Scholar 

  8. Lee, J. M. 1959. Proteolipid as an incitant of “allergic” encephalomyelitis in mice. Pages 272–280,in Kies, M. W. and Alvord, E. C., Jr., (eds.), “Allergic” Encephalomyelitis, Charles C. Thomas, Springfield, Illinois.

    Google Scholar 

  9. Kies, M. W. and Alvord, E. C., Jr., 1959. Encephalitogenic activity in guinea pigs, of water-soluble protein fractions of nervous tissue. Pares 293–299,in Kies, M. W., and Alvord, E. C., Jr., (eds.), “Allergic” Encephalomyelitis Charles C. Thomas, Springfield, Illinois.

    Google Scholar 

  10. Roboz, E., and Henderson, N. 1959. Preparation and properties of water soluble proteins from bovine cord with “allergic”, encephalomyelitic activity. Pages 281–292,in Kies, M. W., and Alvord, E. C., Jr., (eds.), “Allergic” Encephalomyelitis, Charles C. Thomas, Springfield, Illinois.

    Google Scholar 

  11. Kies, M. W., Murphy, J. B., and Alvord, E. C. 1961. Studies of the encephalitogenic factor in guinea pig central nervous system. Pages, 197–206,in Folch-Pi, J., (ed.), Chemical Pathology of the Nervous System, Pergamon Press, Oxford, England.

    Google Scholar 

  12. Roboz-Einstein, E., Robertson, D. M., DiCaprio, J. M., and Moore, W. 1962. The isolation from bovine spinal cord of a homogenous protein with encephalitogenic activity J. Neurochem. 9:353–361.

    Google Scholar 

  13. Kies, M. W., S. Gordon, R. H. Laatsch, and E. C. Alvord, Jr. 1961. Cellular localization of allergic encephalomyelitic activity in guinea pig brain Pages, 20–29,in Jacob, H., (ed.), Proceedings of the International Congress of Neuropathology, Georg Thieme Verlag, Stuttgart, Germany.

    Google Scholar 

  14. Laatsch, R. H., Kies, M. W., Gorden, S., and Alvord, E. C., Jr. 1962. The encephalomyelitic activity of myelin isolated by ultracentrifugation. J. Exp. Med. 115:777–788.

    Google Scholar 

  15. Hulcher, F., Spudis, E. V., and Netsky, M. G. 1963. Encephalomyelitis induced by a white matter fraction. Arch. Neurol. (Chic.) 8:1–7.

    Google Scholar 

  16. Soto, E. F. 1964. Induction of experimental allergic encephalomyelitis with a myelin fraction obtained from bovine white matter. Neurology 14:938–948.

    Google Scholar 

  17. Rauch, H. C., and Raffels, S. 1964. Immunofluorescent localization of encephalitogenic protein in myelin. J. Immunol. 92:452–455.

    Google Scholar 

  18. McFarland, H. F. 1970. Immunofluorescent study of circulating antibody in experimental allergic encephalomyelitis. Proc. Soc. Exptl Biol. Med. 133:1195–1200.

    Google Scholar 

  19. Whittingham, S., Bencina, B., Carnegie, P. R., and McPherson, T. A. 1972. Properties of antibodies produced in rabbits to human myelin, and myelin basic protein. Int. Arch. Allergy Appl. Immunol. 42:250–263.

    Google Scholar 

  20. Herndon, R. M., Rauch, H. C., and Einstein, E. R. 1973. Immuno-electron microscopic localization of the encephalitogenic basic protein in myelin. Immunol. Commun. 2:163–172.

    Google Scholar 

  21. Kies, M. W., Thompson, E. B., and Alvord, E. C., Jr. 1965. The relationship of myelin, proteins to experimental allergic encephalomyelitis. Ann. N. Y. Acad. Sci. 122:148–160.

    Google Scholar 

  22. Kies, M. W. 1965. Chemical studies on an encephalitogenic protein from guinea pig brain. Ann. N.Y. Acad. Sci. 122:161–170.

    Google Scholar 

  23. Lumsden, C. E., Robertson, D. M., and Blight., R. 1966. Chemical studies on experimental allergic encephalitogenic “antigens”. J. Neurochem. 13:127–162.

    Google Scholar 

  24. Trotter, J. L., and Clark, H. B. 1984. Contamination of proteolipid protein with basic protein. Ann Neurol. 16:514.

    Google Scholar 

  25. Lees, M. B., and Cambi, F. 1985. Noncontamination of proteolipid protein preparations by MBP. Ann. Neurol. 18:268.

    Google Scholar 

  26. Pettinelli, C. B. and McFarlin, D. E. 1981. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: Requirement for Lyt 1+2-T lymphocytes. J. Immunol. 127:1420–1423.

    Google Scholar 

  27. Holda, J. H., and Swanborg, R. H., 1982. Autoimmune effector cells. II. Transfer of experimental allergic encephalomyelitis, with a subset of T lymphocytes. Eur. J. Immunol. 12:453–455.

    Google Scholar 

  28. Ben-Nun, A., Wekerle, H., and Cohen, I. R. 1981. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11:195–199.

    Google Scholar 

  29. Ben-Nun, A., Wekerle, H. and Cohen, I. R. 1982. Experimental autoimmune encephalomyelitis (EAE) mediated by cell lines: Process of selection of lines and characterization of the cells. J. Immunol. 129:303–309.

    Google Scholar 

  30. Vandenbark, A. A., Gill, T., and Offner, H. 1985. A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis. J. Immunol. 135:223–228.

    Google Scholar 

  31. Zamvil, S. S., Nelson, P., Trotter, J., Mitchell, D., Knobler, R., Fritz, R., and Steinman, L. 1985. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 317:355–358.

    Google Scholar 

  32. Zamvil, S. S., Mitchell, D. J., Moore, A. C., Kitamura, K., Steinman, S. and Rothbard, J. B. 1986. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324:258–260.

    Google Scholar 

  33. Vandenbark, A. A., Offner, H., Reshef T., Fritz, R., Chou, C.-H.J., and Cohen, I. R. 1985. Specificity of T lymphocyte lines for peptides of myelin basic protein. J. Immunol. 135:229–233.

    Google Scholar 

  34. Sun, D. and Wekerle, H. 1986. Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes. Nature 320:70–72.

    Google Scholar 

  35. Raine, C. S. 1984. Biology of disease. Analysis of autoimmune demyelination: Its impact upon multiple sclerosis. Lab. Invest. 50:608–635.

    Google Scholar 

  36. Brostoff, S. W., and Mason, D. W. 1984. Experimental allergic encephalomyelitis: Successful treatment in vivo with a monoclonal antibody that recognizes T helper cell. J. Immunol. 133:1938–1942.

    Google Scholar 

  37. Swanborg, R. H. 1983. Autoimmune effector cells. V. A. monoclonal antibody specific for rat helper T lymphocytes inhibits adoptive transfer of autoimmune encephalomyelitis. J. Immunol. 130:1503–1505.

    Google Scholar 

  38. Wraith, D. C., McDevitt, H. O., Steinman, L., and Acha-Orbea, H. 1989. T cell recognition as the target for immune intervention in autoimmune disease. Cell 57:709–715.

    Google Scholar 

  39. Steinman, L., Rosenbaum, J. T., Sriram, S., and McDevitt, H. O. 1981. In vivo effects of antibodies to immune response, gene products: Prevention of experimental allergic encephalitis. Proc. Natl Acad. Sci. USA 78:7111–7114.

    Google Scholar 

  40. Sriram, S. and Steinman, L. 1983. Anti I-A antibody suppresses active encephalomyelitis: Treatment model for diseases linked to IR genes. J. Exp. Med. 158:1362–1367.

    Google Scholar 

  41. Sriram, S., Topham, D. J., and Carroll, L. 1987. Haplotype-specific suppression of experimental allergic encephalomyelitis with anti-IA antibodies. J. Immunol. 139:1485–1489.

    Google Scholar 

  42. Happ, M. P., Kiraly, A. S., Offner, H., Vandenbark, A. and Heber-Katz, E. 1988. The autoreactive T cell population in experimental allergic encephalomyelitis: T cell receptor B-chain rearrangements. J. Neuroimmunol. 19:191–204.

    Google Scholar 

  43. Zamvil, S. S., Mitchell, D. J., Lee, N. E., Moore, A. C., Waldor, M. K., Sakai, K., Rothbard, J. B., McDevitt, H. O., Steinman, L., and Acha-Orbea. 1988. Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis J. Exp. Med. 167:1586–1596.

    Google Scholar 

  44. Burns, F. R., Li, X., Shen, N., Offner, H., Chou, Y. K., Vandenbark, A. A. and Heber-Katz, E. 1989. Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin based protein use similar Vα and Vβ chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J. Exp. Med. 169:27–39.

    Google Scholar 

  45. Chluba, J., Steeg, C., Becker, A., Wekerle, H., and Epplen, J. T. 1989 T cell receptor B chain usage in myelin basic protein-specific rat T lymphocytes. Eur. J. Immunol. 19:279–284.

    Google Scholar 

  46. Acha-Orbea, H., Mitchell, D. J., Timmerman, L., Wraith, D. C., Tausch, G. S., Waldor, M. K. Waldor, Zamvil, S. S., McDevitt, H. O., and Steinman, L. 1988. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows, specific immune intervention. Cell 54:263–273.

    Google Scholar 

  47. Urban, J. L., Kumar, V., Kono, D. H., Gomez, C., Horvath, S. J., Clayton, J., Ando, D. G., Sercarz, E. E. Sercarz, and Hood, L. 1988. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577–592.

    Google Scholar 

  48. Howell, M. D., Winters, S. T., Olee, T., Powell, H. C., Carlo, D. J., and Brostoff, S. W. 1989. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246:668–670.

    Google Scholar 

  49. Vandenbark, A. A., Hashim, G., and Offner, H. 1989. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autommune encephalomyelitis. Nature 341:541–544.

    Google Scholar 

  50. Offner, H., Hashim, G. A., and Vandenbark, A. A. 1991. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 251:430–432.

    Google Scholar 

  51. Kumar, V. and E. E. Sercarz. 1993. The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178:909–916.

    Google Scholar 

  52. Bitar, D. M. and Whitacre, C. C. 1988. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell. Immunol. 112:364–370.

    Google Scholar 

  53. Higgins, P. J., and Weiner, H. L. 1988. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140:440–445.

    Google Scholar 

  54. Levine, S., Sowinski, R., and Kies, M. W. 1972. Treatment of experimental allergic encephalomyelitis with encephalitogenic basic proteins. Proc. Soc. Exp. Biol. Med. 139:506–510.

    Google Scholar 

  55. Swierkosz, J. E., and Swanborg, R. H. 1977. Immunoregulation of experimental allergic encephalomyelitis: Conditions for induction of suppressor cells and analysis of mechanism. J. Immunol. 119:1501–1506.

    Google Scholar 

  56. Alvord, E. C., Jr., Shaw, C.-M., and Hruby, S. 1979. Myelin basic protein treatment of experimental allergic encephalomyelitis in monkeys. Ann. Neurol. 6:469–473.

    Google Scholar 

  57. Sriram, S., Schwartz G., and Steinman, L. 1983. Administration of myelin, basic protein-coupled spleen cells prevents experimental allergic encephalitis. Cell. Immunol. 75:378–382.

    Google Scholar 

  58. McKenna, R. M., Carter, B. G., and Sehon, A. H. 1984. Studies on the mechanism of suppression of experimental, allergic encephalomyelitis induced by myelin basic protein-cell conjugates. Cell. Immunol 88:251–259.

    Google Scholar 

  59. Clayton, J. P., Gammon, G. M., Ando, D. G., Kono, D. H., Hood, L., and Sercarz, E. E. 1989. Peptide-specific prevention of experimental allergic encephalomyelitis: Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J. Exp. Med. 169:1681–1691.

    Google Scholar 

  60. Swanborg, R. H. 1973. Antigen-induced inhibition of experimental allergic encephalomyelitis. II. Studies in guinea pigs with the small rat myelin basic protein. J. Immunol. 111:1067–1070.

    Google Scholar 

  61. Swanborg, R. H. 1975. Antigen-induced inhibition of experimental allergic encephalomyelitis. III. Localization of an inhibitory site distinct from the major encephalitogenic determinant of myelin basic protein. J. Immunol. 114:191–194.

    Google Scholar 

  62. Swanborg, R. H. 1972. Antigen-induced inhibition of experimental allergic encephalomyelitis I. Inhibition in guinea pigs injected with non-encephalitogenic modified, myelin basic protein. J. Immunol. 109:540–546.

    Google Scholar 

  63. Kardys, E. and Hashim, G. A. 1981. Experimental allergic encephalomyelitis in Lewis rats: Immunoregulation of disease by a single amino acid substitution in the disease-inducing determinant. J. Immunol., 127:862–866.

    Google Scholar 

  64. Wraith, D. C., Smilek, D. E., Mitchell, D. J., Steinman, L., and McDevitt, H. O. 1989. Antigen recognition, in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59:247–255.

    Google Scholar 

  65. Lees, M. B., Chao, B. H., Lin, L.-F. H., Samiullah, M., and Laursen, R. A. 1983. Amino acid sequence of bovine, white matter proteolipid. Arch. Biochem. Biophys. 226:643.

    Google Scholar 

  66. Weimbs, T., and Stoffel, W. 1992. Proteolipid protein (PLP) of CNS myelin: Positions, of free, disulfide-bonded and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP. Biochemistry 31:12289–12296.

    Google Scholar 

  67. Williams, R. M., Lees, M. B., Cambi, F., and Macklin, W. B. 1982. Chronic EAE induced in rabbits with bovine white matter proteolipid protein. J. Neuropathol. Exp. Neurol. 41:508–521.

    Google Scholar 

  68. Cambi, F., Lees, M. B., Williams, R. M., and Macklin, W. B. 1983. Chronic experimental allergic encephalomyelitis produced by bovine proteolipid apoprotein: Immunological studies in rabbits. Ann. Neurol. 13:303–308.

    Google Scholar 

  69. Cambi, F., and Lees, M. B. 1984. Chronic experimental allergic encephalomyelitis in guinea pigs: Immunologic studies on the two major myelin proteins. Cell. Immunol. 86:567–574.

    Google Scholar 

  70. Endoh, M., Tabira, T., Kunishita, T., Sakai, K., Yamamura, T., and Taketomi, T. 1986. DM-20, a proteolipid apoprotein, is an encephalitogen of acute and relapsing autoimmune encephalomyelitis in mice. J. Immunol. 137:3832–3835.

    Google Scholar 

  71. Satoh, J., Sakai, K., Endoh, M., Koike, F., Kunishita, T., Namikawa, T., Yamamura, T., and Tabira, T. 1987. Experimental allergic encephalomyelitis mediated by murine encephalitogenic T cell lines specific for myelin proteolipid apoprotein. J. Immunol. 138:179–184.

    Google Scholar 

  72. Tuohy, V. K., Sobel, R. A., and Lees, M. B. 1988. Myelin proteolipid protein-induced experimental allergic encephalomyelitis. Variations of disease expression in different strains of mice. J. Immunol. 140:1868–1873.

    Google Scholar 

  73. Touhy, V. K., Lu, Z., Sobel, R. A., Laursen, R. A., and Lees, M. B. 1988. A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis. J. Immunol. 141:1126–1130.

    Google Scholar 

  74. Tuohy, V. K., Lu, Z., Sobel, R. A., Laursen, R. A., and Lees, M. B. 1989. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142:1523–1526.

    Google Scholar 

  75. Endoh, M., Kunishita, T., Nihei, J., Nishizawa, M. and Tabira, T. 1990. Susceptibility to proteolipid apoprotein and its encephalitogenic determinants in mice. Int. Arch. Allergy Appl. Immunol. 92:433–438.

    Google Scholar 

  76. Linington, C., Gunn, C. A., and Lassmann, H. 1990. Identification of an encephalitogenic determinant of myelin proteolipid protein for the rabbit. J. Neuroimmunol. 30:135–144.

    Google Scholar 

  77. Whitham, R. H., Jones, R. E., Hashim, G. A., Hoy, C. M., Wang, R.-Y., Vandenbark, A. A., and Offner, H. 1991. Location of a new encephalitogenic epitope (residues 43–64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJLxPL)F1, mice. J. Immunol. 147:3803–3808.

    Google Scholar 

  78. Tuohy, V. K., R. A. Sobel, Z. Lu, R. A. Laursen, and M. B. Lees. 1992. Myelin proteolipid protein: Minimum sequence requirements for active induction of autoimmune encephalomyelitis in SJL/J and SWR/J mice. J. Neuroimmunol. 39:67–74.

    Google Scholar 

  79. Greer, J. M., Kuchroo, V. K., Sobel, R. A., and Lees, M. B. 1992. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178–191) for SJL mice. J. Immunol. 149:783–788.

    Google Scholar 

  80. Amor, A., D. Baker, N. Groome, and J. L. Turk. 1993. Identification of a major encephalitogenic epitope of proteolipid protein (residues 56–70) for the induction of, experimental allergic encephalomyelitis in Biozzi AB/H and nonbese, diabetic mice. J. Immunol. 150:5666–5672.

    Google Scholar 

  81. Tuohy, V. K. and Thomas, D. M. 1993. A third encephalitogenic determinant of myelin proteolipid protein (PLP) for SJL/J mice. J. Immunol. 150:194A (abstr. 1105).

    Google Scholar 

  82. Trotter, J. L., Clark, H. B., Collins, K. G., Wegeschiede, C. L., and Scarpellini, J. A. D. 1987. Myelin proteolipid protein induces demyelinating disease in mice. J. Neurol. Sci. 79:173–188.

    Google Scholar 

  83. van der Veen, R. C., Trotter, J. L., Clark, H. B., and Kapp, J. A. 1989. The adoptive transfer of chronic relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein. J. Neuroimmunol. 21:183–191.

    Google Scholar 

  84. McRae, B. L., Kennedy, M. K., Tan, L. J., Dal Canto, M. C., Picha, K. S., and Miller, S. D. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalotigenic, epitope of proteolipid protein. J. Neuroimmunol. 38:229–240.

  85. Tuohy, V. K., Sobel, R. A., and Lees, M. B. 1988. Susceptibility to PLP-induced EAE is regulated by non H-2 genes. Ann. N.Y. Acad. Sci. 540:709–711.

    Google Scholar 

  86. Hoffman, P. M., Gaston, D. D., and Spitler L. E. 1973. Comparison of experimental allergic encephalomyelitis induced with spinal cord, basic protein, and synthetic encephalitogenic peptide. Clin. Immunol. Immunopathol. 1:364–371.

    Google Scholar 

  87. Raine, C. S., Traugott, U., Iqbal, K., Snyder, D. S., Cohen, S. R., Farooq, M., and Norton, W. T. 1978. Encephalitogenic properties of purified preparations of bovine oligodendrocytes tested in guinea pigs. Brain Res. 142:85–96.

    Google Scholar 

  88. Hashim, G. A., Wood, D. D., and Moscarello, M. A. 1980. Myelin lipophilin-induced demyelinating disease of the central nervous system. Neurochem. Res. 5:1137–1145.

    Google Scholar 

  89. Panitch, H., Ciccone, C. 1981. Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein. Ann. Neurol. 9:433–438.

    Google Scholar 

  90. Moore, G. R. W., Traugott, U., Stone, S. H., and Raine, C. S. 1985. Dose-dependency of MBP-induced demyelination in the guinea pig. J. Neurol. Sci. 70:197–205.

    Google Scholar 

  91. Yoshimura, T., Kunishita, T., Sakai, K., Endoh, M., Namikawa, T., and Tabira, T. 1985. Chronic allergic encephalomyelitis in guinea pigs induced by proteolipid protein. J. Neurol. Sci. 69:47–58.

    Google Scholar 

  92. Yamamura, T., Namikawa, T., Endoh, M., Kunishita, T., and Tabira, T. 1986. Experimental allergic encephalomyelitis induced by proteolipid apoprotein in Lewis rats. J. Neuroimmunol. 12:143–153.

    Google Scholar 

  93. Raine, C. S., Barnett, L. B., Brown, A., Behar, T., and McFarlin, D. E. 1980. Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab. Invest. 43:150–157.

    Google Scholar 

  94. Tabira, T., and Sakai, K. 1987. Demyelination induced by T cell lines and clones specific for myelin basic protein in mice. Lab. Invest. 56:518–525.

    Google Scholar 

  95. van der Veen, R. C., Trotter, J. L., Hickey, W. F., and Kapp, J. A. 1990. The development and characterization of encephalitogenic cloned T cells specific for myelin proteolipid protein. J. Neuroimmunol. 26:139–145.

    Google Scholar 

  96. Kuchroo, V. K., Sobel, R. A., Yamamura, T., Greenfield, E., Dorf, M. E., and Lees, M. B. 1991. Induction, of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides. Pathobiol. 59:305–312.

    Google Scholar 

  97. Kuchroo, V. K., Sobel, R. A., Laning, J. C., Martin, C. A., Greenfield, E., Dorf, M. E., and Lees, M. B. 1992. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor V beta usage. J. Immunol. 148:3776–3782.

    Google Scholar 

  98. Sobel, R. A., and Kuchroo, V. K. 1992. The immunopathology of acute, experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions. J. Immunol. 149:1444–1451.

    Google Scholar 

  99. Hickey, W. F., Hsu, B. L., and Kimura., H. 1991. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28:254–260.

    Google Scholar 

  100. Ishioka, G., Franco, A., Southwood, S., Oseroff, C., Grey, H., and Sette, A. 1993. T cells receptor antagonism of EAE induced by PLP 139-151 peptide in SJL/J mice. J. Immunol. 150:94A (abstr. 524).

    Google Scholar 

  101. Lamont, A. G., Sette, A., Fujinami, R., Colon, S. M., Miles, C., and Grey, H. 1990. Inhibition of experimental autoimmune encephalomyelitis induction, in SJL/J mice by using a peptide with high affinity for IAs molecules. J. Immunol. 145:1687–1693.

    Google Scholar 

  102. Kennedy, M. K., Tan, L. J., Dal Canto, M. C., Tuohy, V. K., Lu, Z. J., Trotter, J. L., and Miller, S. D. 1990. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid, protein and its encephalitogenic peptides. J. Immunol. 144:909–915.

    Google Scholar 

  103. Whitham, R. H., Bourdette, D. N., Hashim, G. A., Herndon, R. M., Vandenbark, A. A., and Offner, H. 1991. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 146:101–107.

    Google Scholar 

  104. Sobel, R. A., Tuohy, V. K., Lu, Z., Laursen, R. A., and Lees, M. B. 1990. Acute experimental allergic encephalomyelitis in SJL/J mice induced by a synthetic peptide of myelin proteolipid protein. J. Neuropath. Exp. Neurol. 49:468–479.

    Google Scholar 

  105. Fontana, A., Fierz, W., and Wekerle, H. 1984. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 307:273–276.

    Google Scholar 

  106. Massa, P. T., Dorries, R., and ter Meulen, V. 1986. Viral particles induce Ia antigen expression on astrocytes. Nature 320:543–546.

    Google Scholar 

  107. Sobel, R. A., Tuohy, V. K., and Lees, M. B. 1991. Parental MHC molecule haplotype expression in (SJL/JxSWR)F1 mice with acute experimental allergic encephalomyelitis induced with two different synthetic peptides of myelin proteolipid protein. J. Immunol. 146:543–549.

    Google Scholar 

  108. Hickey, W. F., and Kimura, H. 1988. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290–292.

    Google Scholar 

  109. van der Veen, R. C., Trotter, J. L., and Kapp, J. A. 1992. Immune processing of proteolipid protein by subsets of antigen-presenting spleen cells. J. Neuroimmunol. 38:139–146.

    Google Scholar 

  110. Myers, K. J., Dougherty, J. P., and Ron, Y. 1993. In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the, induction of experimental autoimmune encephalomyelitis. J. Immunol. 151:2252–2260.

    Google Scholar 

  111. van der Veen, R. C., Sobel, R. A., and Lees, M. B. 1986. Chronic experimental allergic encephalomyelitis and antibody responses in rabbits immunized with bovine proteolipid aporotein. J. Neuroimmunol. 11:321–333.

    Google Scholar 

  112. Endoh, M., Tabira, T., and Kunishita, T. 1986. Antibodies to proteolipid apoprotein in chronic relapsing experimental allergic encephalomyelitis. J. Neurol. Sci. 73:31–38.

    Google Scholar 

  113. Potter, N. and Lees, M. B. 1988. Immunohistochemical characterization of antibodies to the myelin proteolipid protein (PLP). J. Neuroimmunol. 18:49–60.

    Google Scholar 

  114. Gunn, C. A., Richards, M. K., and Linington, C. 1990. The immune response to myelin proteolipid protein in the Lewis rat: Identification of the immunodominant B cell epitope. J. Neuroimmunol. 27:155–162.

    Google Scholar 

  115. Yamamura, T., Konola, J. T., Wekerle, H., and Lees, M. B. 1991. Monoclonal antibodies against myelin proteolipid protein: Identification and characterization of two major determinants. J. Neurochem. 57:1671–1680.

    Google Scholar 

  116. Perry, L. L., Barzaga-Gilbert, E., and Trotter, J. L. 1991. T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 33:7–15.

    Google Scholar 

  117. McCarron, R. M., Fallis, R. J., and McFarlin, D. E. 1990. Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 29:73–79.

    Google Scholar 

  118. Lehmann, P. V., Forsthuber, T., Miller, A., and Sercarz, E. E. 1992. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155–157.

    Google Scholar 

  119. Cross, A. H., Tuohy, V. K., and Raine, C. S. 1993. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell. Immunol. 146:261–269.

    Google Scholar 

  120. van der Veen, R. C., and S. A. Stohlman. 1993. Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: Relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol. 48:213–220.

    Google Scholar 

  121. Barnett, L. A., Whitton, J. L., and Fujinami, R. S. 1991. Modulation of experimental allergic encephalomyelitis using vaccinia virus constructs containing myelin proteins. Brain Pathol. 1:314 (abstr.)

    Google Scholar 

  122. Barnett, L. A., Whitton, J. I., Wada, Y., and Fujinami, R. S., 1993. Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J. Neuroimmunol. 44:15–26.

    Google Scholar 

  123. Barnett, L. A., Whitton, J. L. and Fujinami, R. S. 1993. Immunomodulation of CNS autoimmune disease using vaccinia virus encoding myelin proteins. J. Immunol. 150:174A (abstr. 991)

    Google Scholar 

  124. Johnson, D., Hafler, D. A., Fallis, R. J., Lees, M. B., Brady, R. O., Quarles, R. H., and Weiner, H. L. 1986. Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis. J. Neuroimmunol. 13:99–108.

    Google Scholar 

  125. Hafler, D. A., Benjamin, D. S., Burks, J. and Weiner, H. L. 1987. Myelin basic protein and proteolipid protein reactivity of brain-and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis. J. Immunol. 139:68–72.

    Google Scholar 

  126. Olsson, T., Zhi, W. W., Hojeberg, B., Kostulas, V., Jiang, Y. P., Anderson, G., Ekre, H. P., and Link, H. 1990. Autoreactive T lymphocytes in multiple sclerosis determined, by antigen-induced secretion of interferon-gamma. J. Clin. Invest. 86:981–985.

    Google Scholar 

  127. Sun, J.-B., Olsson, T., Wang, W.-Z., Xiao, B.-G., Kostulas, V., Fredrikson, S., Ekre, H.-P., and Link, H. 1991. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur. J. Immunol. 21:1461–1468.

    Google Scholar 

  128. Trotter, J. L., Hickey, W. F., van der Veen, R. C., and Sulze, L. 1991. Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides. J. Neuroimmunol. 33:55–62.

    Google Scholar 

  129. Chou, Y. K., Bourdette, D. N., Offner, H., Whitham, R., Wang, R. Y., Hashim, G. A., and Vandenbark, A. A. 1992. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J. Neuroimmunol. 38:105–113.

    Google Scholar 

  130. Inobe, J., Yamamura, T., Kunishita, T., and Tabira, T. 1992. Multiple T-cell epitopes of myelin proteolipid protein (PLP) in Japanese multiple sclerosis (MS). Neurology 42(Suppl. 3):159–160 (abstr. 87P).

    Google Scholar 

  131. Kinkel, R. P. and Tuohy, V. K. 1992. Immune response to myelin proteolipid protein (PLP) in MS. Neurology 42(Suppl. 3) 159 (abstr. 87P).

    Google Scholar 

  132. Pelfrey, C. M., Trotter, J. L., Tranquill, L. R., and MacFarland, H. F. 1993. Identification of a novel T cell epitope of human proteolipid protein (residues 40–60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients. J. Neuroimmunol. 46:33–42.

    Google Scholar 

  133. Trotter, J. L., Bryan, J., Pelfrey, C., and McFarland, H. 1993. Myelin proteolipid protein peptides which are recognized by T cell lines from human subjects with MS. J. Immunol. 150:196A (abstr. 1117)

    Google Scholar 

  134. Baxevanis, C. N., Reclos, G. J., Servis, C., Anastasopoulos, E., Arsenis, P., Katsiyiannis, A., Matikas N., Lambris, J. D., and Papamichail, M. 1989. Peptides of myelin basic protein stimulate T lymphocytes from patients with multiple sclerosis. J. Neuroimmunol. 22:23–30.

    Google Scholar 

  135. Richert, J. R., Robinson, E. D., Deibler, G. E., Martenson, R. E., Dragovic, L. J., and Kies, M. W. 1989. Human cytotoxic T-cell recognition of a synthetic peptide of myelin basic protein. Ann. Neurol. 26:342–346.

    Google Scholar 

  136. Richert, J. R., Robinson, E. D., Deibler, G. E., Martenson, R. E., Dragovic, L. J., and Kies, M. W. 1989. Evidence for multiple human T cell recognition sites on myelin basic protein. J. Neuroimmunol. 23:55–66.

    Google Scholar 

  137. Allegretta, M., Nicklas, J. A., Sriram, S., and Albertini, R. J. 1990. T cells responsive to myelin basic protein in patients with multiple, sclerosis. Science 247:718–721.

    Google Scholar 

  138. Ota, K., Matsui, M., Milford, E. L., Mackin, G. A., Weiner, H. L., and Hafler, D. A. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183–187.

    Google Scholar 

  139. Wucherpfennig, K. W., Ota, K., Endo, N., Seidman, J. G., Rosenzweig, A., Weiner, H. L., and Hafler, D. A. 1990. Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science 248:1016–1019.

    Google Scholar 

  140. Richert, J. R., Robinson, E. D., Johnson, A. H., Bergman, C. A., Dragovic, L. J., Reinsmoen, N. L., and Hurley, C. K. 1991. Heterogeneity of the T-cell receptor beta gene rearrangements generated in myelin basic protein-specific T-cell clones isolated from a patient with multiple sclerosis. Ann. Neurol. 29:299–306.

    Google Scholar 

  141. Martin, R., Utz, U., Coligan, J. E., Richert, J. R., Flerlage, M., Robinson, E., Stone, R., Biddison, W. E., McFarlin, D. E., and McFarland, H. F. 1992. Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87–106. J. Immunol. 148:1359–1366.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunology, FFb-48, The Cleveland Clinic Foundation, 9500 Euclid Evanue, 44195, Cleveland, OH

    Vincent K. Tuohy

Authors
  1. Vincent K. Tuohy
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Special Issue dedicated to Dr. Majorie B. Lees.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tuohy, V.K. Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: A review. Neurochem Res 19, 935–944 (1994). https://doi.org/10.1007/BF00968703

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00968703

Key Words

Search

Navigation